| NCT ID | NCT05981755 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Health Science Center, Houston |
| Condition | Focal Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-07-31 |
| Primary Completion | 2028-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-07-31 with a primary completion date of 2028-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to precisely delineate human brain networks that modulate respiration and identify specific brain areas and stimulation techniques that can be used to prevent seizure-induced breathing failure.
Eligibility Criteria
Inclusion Criteria: * diagnosis of intractable focal epilepsy * admitted to the Epilepsy Monitoring Unit (EMU) at Memorial Hermann-Texas Medical Center for intracranial subdural strips, grids, or depth electrode placement study (invasive video-EEG) Exclusion Criteria: * respiratory, cardiac or cerebrovascular disease * pregnancy * prisoners
Contact & Investigator
Nuria L Lecumberri, MD,PhD
PRINCIPAL INVESTIGATOR
The University of Texas Health Science Center, Houston
Frequently Asked Questions
Who can join the NCT05981755 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Focal Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05981755 currently recruiting?
Yes, NCT05981755 is actively recruiting participants. Contact the research team at Nuria.Lacuey@uth.tmc.edu for enrollment information.
Where is the NCT05981755 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT05981755 clinical trial?
NCT05981755 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Nuria L Lecumberri, MD,PhD at The University of Texas Health Science Center, Houston. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.